BCR-ABL1 F317V
|
CML
|
BCR-ABL1 F317V
|
CML
|
dasatinib Resistant: A2 - Guideline
|
dasatinib Resistant: A2 - Guideline
|
BCR-ABL1 F317V
|
ALL
|
BCR-ABL1 F317V
|
ALL
|
dasatinib Resistant: A2 - Guideline
|
dasatinib Resistant: A2 - Guideline
|
BCR-ABL1 F317V
|
CML
|
BCR-ABL1 F317V
|
CML
|
nilotinib Resistant: D – Preclinical
|
nilotinib Resistant: D – Preclinical
|